Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,260.00
+110.00 (2.14%)
Apr 10, 2026, 3:30 PM KST
Market Cap323.70B -23.0%
Revenue (ttm)90.90B +36.9%
Net Income15.00B +6.0%
EPS149.00 -39.7%
Shares Out61.54M
PE Ratio35.30
Forward PEn/a
Dividend50.00 (0.97%)
Ex-Dividend DateDec 29, 2025
Volume140,730
Average Volume231,906
Open5,170.00
Previous Close5,150.00
Day's Range5,170.00 - 5,290.00
52-Week Range4,510.00 - 8,420.00
Beta0.47
RSI53.82
Earnings DateApr 3, 2026

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2003
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 099430
Full Company Profile

Financial Performance

In 2025, Bio Plus's revenue was 90.90 billion, an increase of 36.87% compared to the previous year's 66.41 billion. Earnings were 15.00 billion, an increase of 6.01%.

Financial Statements